Monthly Archives: June 2020

DNA unlocks the secrets of the Dead Sea Scrolls – Haaretz

Posted: June 13, 2020 at 4:48 pm

Over 70 years ago, a Bedouin shepherd named Muhammed ed-Dib entered a cave in the Qumran area west of the Dead Sea. In it he found large clay jars containing parchment scrolls wrapped in linen. Ed-Dib didnt know it, but he had stumbled upon the first pieces of one of the most important archaeological discoveries of the 20th century, which would come to be known as the Dead Sea Scrolls. The scrolls opened a window to the spiritual world and quotidian life of the Second Temple period one of the most tempestuous eras in Jewish history and shed light on the process by which various Jewish sects sprang up during that time, one of which would morph into Christianity. But even today these archaeological finds continue to raise more questions than answers.

A major reason for the contentious disputes is that the collection of scrolls in Israel today consists of nearly 25,000 fragments of parchment and papyrus (the lions share of all the known scroll artifacts in the world) which, it is estimated, come from more than 930 different ancient manuscripts. This vast jigsaw puzzle, with an unknown number of pieces that have been lost over time, includes the earliest versions found to date of all the books of the Hebrew Bible (with the exception of the Book of Esther), as well as the biblical apocrypha and many other works previously unknown.

The conventional theory is that some of those works were written or copied by a zealous Jewish sect, identified by most scholars as the Essenes, who led an ascetic life in the desert. However, there is now general agreement that the collection also includes scrolls that originated from outside the sect, written by other learned individuals of that period. Accordingly, the question of which texts are unique to the sect and which were brought in from outside is crucial for understanding the significance of the texts, and to what extent they represent the ideas in currency in Judea of the latter Second Temple period (334 B.C.E.-70 C.E.). A study published this week as the cover story of the scientific journal Cell has harnessed the most advanced tools of biological research in order to help solve the mystery.

The study was conducted by researchers from Tel Aviv University, led by Prof. Oded Rechavi, from the George S. Wise Faculty of Life Sciences and the Sagol School of Neuroscience, and Prof. Noam Mizrahi from the department of biblical studies, in collaboration with Prof. Mattias Jakobsson of Uppsala University in Sweden, the Israel Antiquities Authority, Prof. Dorothee Huchon-Pupko from TAUs zoology department, and Prof. Christopher E. Mason of Weill Cornell Medicine.

Using techniques of DNA sequencing and sophisticated methods of computation, the scientists were able to identify and catalog 26 parchment fragments (plus another 13 leather artifacts) according to the DNA of the animals on whose skins the scrolls were written, and thus to determine which fragments are related to one another, and which ones not.

There are many scrolls fragments that we dont know how to connect, and if we connect wrong pieces together it can change dramatically the interpretation of any scroll, says Prof. Rechavi. Assuming that fragments that come from the same sheep belong to the same scroll, it is like piecing together parts of a puzzle.

The methods the researchers employed have already helped to shed light on a host of important historical and religious issues: how the concept of sacredness in regard to the texts of biblical books changed over time; when basic notions arose in the realm of Jewish mysticism from which the kabbala sprang; and what the origin was of the idea that prayer could replace sacrificial offerings an idea that was formerly thought to have emerged only following the destruction of the Second Temple, in 70 C.E.

But before applying themselves to matters of remote Jewish history, the researchers had first to overcome a series of challenges, starting with how to collect the sensitive samples. In most cases, to avoid damage to the priceless antiquities, the researchers extracted DNA from tiny scroll crumbs (dust) that fell off, or were scraped off the backs of the fragments. The researchers even demonstrated that they could retrieve authentic ancient DNA from adhesive tape used in the 1950s to piece fragments together that was removed from scrolls.

We were not even allowed to touch the scrolls, says Dr. Sarit Anava, from Rechavis laboratory at TAU. The solution, she explains, was for the Israel Antiquities Authority, which stores all of the scroll pieces in its laboratories at the Israel Museum, to place the samples in test tubes, which she took to Sweden to the laboratory of geneticist Mattias Jakobsson at Uppsala University, which was specially adapted to enable the isolation of ancient genetic materials. In this way, a scroll-crumb is transformed into a window onto Jewish history.

Weve thought for years that the scrolls DNA should be examined, says Prof. Jonathan Ben-Dov, an expert on the Dead Sea Scrolls from the University of Haifas department of Jewish history and biblical studies. Everyone waited for it to happen, and it finally succeeded, adds Ben-Dov, who was not involved in the new study.

If so, what has been discovered?

Comparing texts

The first insight divined by the researchers related to the way inhabitants of Judea in the Second Temple period viewed the texts of the Bible. Apparently, the Judaism of that era didnt have one standard version of each of the sacred texts; in other words, not every jot and tittle in the Bible was regarded with the same holiness it would later possess. The scholars reached this conclusion by examining four fragments of parchment containing sections from the Book of Jeremiah.

Today all editions of the Hebrew Bible are absolutely identical, down to the letter. This was the case even before the invention of printing, in fact since the emergence of the authoritative Masoretic Text of the Bible in Tiberias in the early Middle Ages a version that has been preserved almost without alteration to this day. However, other, even-older versions of the Scriptures also exist, notably the Septuagint. This Greek translation of the Hebrew Bible, originating in Alexandria and dating to the third and second centuries B.C.E., was eventually adopted by the Greek Orthodox Church and remains in use today. The differences between the Masoretic Text and the Septuagint are especially striking in Jeremiah.

Its not a matter of the interchange of a letter here and there, or differences between a few isolated words, says Noam Mizrahi, the biblical scholar. The Septuagint text of Jeremiah is 15 percent shorter than the long version reflected in the Masoretic Text. Furthermore, the two texts differ in the way their sections are arranged; in some of the prophecies there are differences in the order and in the content of the verses. The result is, in effect, completely different editions of the prophetic text, and at times entirely different texts.

Differences of this sort in the books of the Hebrew Bible disappeared in the wake of the destruction of the Temple.

What remained are smaller differences at the orthographical level, which persisted into the Middle Ages because the books were copied by hand, Mizrahi continues. In late antiquity and the Middle Ages, rigorous mechanisms of quality control were applied, which ensured that the differences would hardly ever affect an understanding of the content.

Which versions of Jeremiah appear on the scroll fragments examined by the research team? One fragment contains a long version close the Masoretic text, two contain a short version that resembles the Septuagint, and a fourth has a different, independent text.

Mizrahi: There was a scholarly debate over three of these segments, about whether they originally belonged to the same scroll or came from different scrolls, because they look very similar to each other but differ in the handwriting of the copyist.

Enter genetic classification: The scientists discovered that the vast majority of scroll pieces they examined were written on the skin of sheep an animal that could also be bred in the climatic conditions of the Judean Desert 2,000 years ago. The fragments of the Book of Jeremiah that stirred debate, however, were written on the skins of two different animals: two on sheep and two on the skin of a cow, an animal that was not ordinarily raised in the Judean Desert.

For the scientists, discovery of which animal skin was used for copying the texts represents a significant, genetic confirmation of the hypothesis that the writing was not solely the work of the desert sect but of someone from the outside.

Cow-skin scrolls were manifestly not produced there, but originated externally, Mizrahi says. And while theoretically they might have been brought to Qumran as blank parchments, such a scenario makes very little sense from a practical and economic point of view, so it seems they were brought already as written manuscripts. The conclusion that these are two separate versions of Jeremiah neither of which, apparently, was copied by the local sect, but rather originated in a different context and place, points to the possibility that an openness to divergent texts of the Holy Scriptures reflects a more general approach in Judea at that time.

He adds, As long as there was only the Greek translation, it could be argued that [the existence of different versions could be attributed to] the Diaspora [the Jews of Alexandria]. But the scrolls indicate that the multiplicity of versions was a basic feature of Judaism as a whole, during that period, and particularly in Judea.

According to Prof. Michael Segal an expert in the Dead Sea Scrolls and the dean of humanities at the Hebrew University of Jerusalem the new findings are consistent with a current theory that holds that some of the scrolls came from outside Qumran. One reason is that some of them antedate the founding of the community itself, notes Segal, who was not involved in the current study. To which Jonathan Ben-Dov adds, We have been playing with theories about the biblical text for hundreds of years. Now, thanks to biology, we have an Archimedes fulcrum, with whose aid we can examine those theories.

Heavenly temple

One of the greatest challenges of DNA research is to locate genetic material of sufficiently high quality to enable laboratory analysis. According to Prof. Yitzhak Pilpel, head of the molecular genetics department of the Weizmann Institute of Science in Rehovot, who was not involved in the study, this is particularly true in cases of genetic samples that need to be extracted from the most minuscule fragments of ancient relics. To overcome this obstacle, scientists involved in the new research used a variety of methods that enabled them to examine the surviving ancient genetic material at different resolutions. For example, the species of animal from which the scrolls were fashioned sheep or cow was identified by comparing sections of the mitochondrial DNA found in the cells of the parchment skin to that of more than 10 species of animals until a match was found. Other methods allowed the scientists to determine the genetic relationship between the different sheep whose skins were used in creating the scrolls.

The second method analyzing the basic genetic groups (haplogroups) of the sheep made it possible for the researchers to derive insight concerning Songs of the Sabbath Sacrifice, one of the most intriguing and important texts found in the Qumran scrolls.

This is a composition that was unknown before the discovery of the scrolls, but 10 copies of it were found among the scrolls themselves clear evidence of its importance, Prof. Mizrahi explains. What was not clear was whether the importance of Songs of the Sabbath Sacrifice was unique to the sectarian group that left the scrolls behind, or whether it represents the works popularity among a broader community.

One reason for the considerable interest in this composition is that one copy of the Songs was found 55 kilometers south of the Qumran caves, in the excavations on Mt. Masada. Many scholars had discerned a connection between the discoveries at both sites. In their view, during the Great Revolt of 66-70 C.E, when the Romans who ruled the country were preparing to lay siege to Jerusalem, and the Qumran community was annihilated the sects survivors fled and joined the Jewish rebels who had barricaded themselves at Masada.

The new study calls this hypothesis into question, at least as far as the textual evidence is concerned. A comparison of the DNA of the sheep showed that the scrolls found at Qumran were all made from animals belonging to one genetic population group, whereas the scroll found at Masada was made from the skin of a sheep from a different group.

We did not expect that result, Mizrahi admits. It shows that it is unlikely that this copy of the Songs was brought to Masada by a refugee from Qumran, because this scroll differs biologically, materially, from the scrolls found at Qumran.

According to Ben-Dov, the new biological information thats come to light does not rule out a connection between the sites. After all, the study itself showed that at Qumran there were scrolls made from the skin of different animals, such as cows, he says. Still, he adds, the findings reinforce the possibility that the Masada scroll is not directly connected to Qumran. This possibility that this religious work was widely circulated in the Judea at that time, outside the sect has significant implications for understanding the spiritual life of Second Temple Judea.

Mizrahi adds that discovering the source of the copies of Songs of the Sabbath Sacrifice is particularly important, because of the uniqueness of the text. It is a liturgical composition a collection of Sabbath prayers but also contains an internal narrative. It describes the heavenly temple and the angels rite of worship. It can be inferred, then, that the authors and readers of the text assumed that there is in heaven a temple parallel to the earthly one and that angel-priests in it are engaged in worship. However, activity in the heavenly temple did not center around offering sacrifices as was true in the Jerusalem Temple, but focused on nonstop uttering of praises of God.

Why is this important? This was a period when the Temple was still operating, Mizrahi explains. The conventional view of researchers until a generation ago was that the idea of fixed and statutory prayer replacing sacrificial offerings in the Temple emerged in Judaism only after the destruction of the Second Temple. Accordingly, at the dawn of Qumran studies, the approach that derived from analysis of the Dead Sea Scrolls and the discovery of the prayer collections they contain, was that the Judean Desert sect predated Judaisms transition from sacrificial rituals to the practice of prayer. Scholars in the past explained that the disputes between different sects of the Second Temple period sects, and the insistence of one of them on particularly strict rules of ritual purification led to the latter keeping their distance from the Jerusalem Temple and remaining secluded in the desert hence their development of the idea of prayers as a substitute.

However, Mizrahi says now, this hypothesis needs to be reconsidered in light of the discovery that the Masada copy of Songs of the Sabbath Sacrifice is not genetically linked to the Qumran copies.

It turns out that the idea of prayer as the center of worship was popular beyond Qumran. Were these other communities of the [same] sect that lived in other places? Possibly, he says, referring to a theory that offshoots of the main sect were active elsewhere. But now we know that the centrality of prayer in the worship of God was not unique to Qumran.

Beyond this, there are additional distinctive features of the Songs of the Sabbath Sacrifice, among them elements that would surface centuries later in early Jewish mystical writings known as Hekhalot and Merkhavah (literally, the Heavenly Palaces and the Divine Chariot-Throne) literature. This is a collection of mystical compositions of which the earliest manuscripts were found in the Cairo Genizah. Scholars are divided about the dating of the original works, but its conventionally thought that they were written in the second half of the first millennium C.E.

Says Mizrahi: This is the oldest layer of Jewish mystical literature, and the foundation on which other mystical doctrines were built, including what would subsequently feed the kabbala literature.

For example, the concept of the chariot of God, which first appears in Ezekiel, develops in the Songs of the Sabbath Sacrifice and hundreds of years later in the Hekhalot literature into the idea that the believer can, through a spiritual journey, be elevated to the heavenly temple, enter the Holy of Holies and see Gods chariot. For 30 years, scholars have been arguing about the nature of the connection between the Songs of the Sabbath Sacrifice and the mystical literature that appeared later.

Over the years, the discovery of this text and the fact that it was attributed to the Qumran community contributed to cultivating the notion that the sect served as a source of inspiration for ideas that later informed Jewish and Christian mysticism. The problem was that until now, no one knew exactly how the transition came about.

As long as Songs of the Sabbath Sacrifice was perceived as a work unique to Qumran, there was a missing link between Qumran and the whole mystical tradition that develops in late antiquity, the early Middle Ages and afterward, Mizrahi says. But if we know now that Songs of the Sabbath Sacrifice was a work that was known outside Qumran and until now there was no clear sign of that then we can understand that there were other channels of transmission of these texts and ideas that bridge the missing link.

Scroll clusters

Another significant achievement of the new genetic study is to reinforce one of the leading methods today for classifying the Dead Sea Scrolls, which until now was based on an analysis of the way they were written. For this purpose, the scientists analyzed sheep sequence variation in the nuclear genome, by means of deep DNA sequencing and algorithms developed by Moran Neuhof, Dr. Hila Gingold and Or Sagy from Prof. Rechavis laboratory. These comparisons enabled them to distinguish between a cluster of scrolls made from sheep bearing high genetic similarities, and scrolls made from sheep that do not belong to this cluster and that are also genetically remote from one another.

This time the researchers applied DNA analysis to the nuclear sheep genome (rather than the mitochondrial genome, which doesnt allow distinguishing between individual sheep), to evaluate the system of classification proposed by Prof. Emanuel Tov, who was editor-in-chief of the international Dead Sea Scrolls Publication Project. The Bible scholar classified the findings into two groups according to 20 scribal signs, such as how the authors of the scrolls inserted corrections, spelled words, marked the explicit name of God (the Tetragrammaton) and so on. According to this classification method, presented in a series of publications, principally during the 1930s, the overwhelming majority of the texts possessing a content unique to the members of the Qumran sect match one scribal style, which was labeled QSP (Qumran Scribal Practice). According to Tov, these scrolls were written by the sects scribes. Tov believes that the other scrolls found at Qumran, labeled Non-QSP, were probably brought to the sect from the outside.

It turns out that all the scrolls we sampled whose nuclear DNA indicates that they belong to one cluster, namely that they are genetically close, were classified as QSP scrolls, whereas the Non-QSP scrolls belong to different clusters, Rechavi says.

Ben-Dov notes that in recent years the theory about the Qumran scribal practice came in for criticism, but now the researchers have shed new light on the subject. Until now this group of scrolls was characterized according to philological markers, and now we also have biological markers, he says.

In addition, the fact that no genetic similarity was found between the external scrolls and the first cluster nor between any of those scrolls in the external cluster supports the hypothesis that the Non-QSP scrolls originated in various places throughout Judea. One of the copies of Songs of the Sabbath Sacrifice found in Qumran now turns out to belong to the second cluster as well.

This is further reinforcement for the hypothesis that the Songs was widespread outside the sects circles, Rechavi avers.

One of the reasons for the confusion about the connection between different scroll fragments stems from the way they were found. Only about a quarter of the scrolls were found in situ by archaeologists, while most were found by Bedouin and sold to researchers in the 1950s, with the sellers not always having an interest in saying exactly where the valuable antiquities had come from. Now, with the aid of the new genetic tools, the scientists are able to unravel part of the tangle, and identify mistakes of earlier researchers. For example, the study found that a fragment from Isaiah, which until now was cataloged as part of the Qumran scrolls, deviates genetically from all the other Qumran scrolls. This raises intriguing questions: Did the fragment really come from the Qumran caves, or perhaps from a place that hasnt yet been identified? Mizrahi notes, adding, Perhaps segments resembling it are still lurking among the 25,000 scroll fragments found to date.

What next? Pnina Shor, founder of the Dead Sea Scrolls Project unit in the Israel Antiquities Authority, who took part in the research study, notes that the authority is working to enlist state-of-the-art scientific tools in an effort to improve the deciphering and preservation of the scrolls. With the aid of international collaboration, the IAA is now drawing on tools such as artificial intelligence to make progress in assembling the physical and textual jigsaw puzzle. Another plan is to make use of a particle accelerator to read segments of a scroll that congealed, rendering it impossible to separate its layers. The IAA is also adopting the biological tools. The present study is proof of its feasibility, Shor says.

The study examined only a small number of the scrolls, but according to the scientists a promising path to solving the riddles residing in the Qumran scrolls lies in expanding the use of genetic analysis. The development of the methods that made the latest breakthroughs possible took years, but the researchers are convinced that the next stage will be far more rapid. Rechavi: I hope we will be able to sample a large number of scrolls and discover how to put the puzzle together.

According to Prof. Oren Harman, a historian of science from Bar-Ilan University, the use of ancient DNA is like the invention of a new tool, like the microscope or the telescope. It allows us to tell a new story, sometimes a different story from the one the archaeologists, anthropologists and historians told until now. Like every scientific tool, emphasizes Harman, who was not involved in the study, ancient DNA should also serve to solve good questions, and not stand on its own. Its important to remember that analysis of the results of studies that rely on ancient DNA is based on a statistical interpretation of the data, and that different interpretations are possible for the same data.

Prof. Pilpel, the molecular geneticist, notes that the researchers conclusions about the scrolls they examined appear to be solid. One of the reasons for this is the choice of scrolls that are of interest if it is shown that they are not connected to one another. It is easier to establish that two sections of skin do not belong to the same animal all you have to do is show that there are a certain number of differences in the DNA, and that can be done even if the genetic material that remains is of low quality.

The various Bible scholars surveyed by Haaretz all say they are certain that even if the biological information serves only to show that different scroll fragments do not match one another, there are many fascinating questions to ask with the use of this tool. There is hope of achieving a more accurate classification of the scrolls in the future, says Michael Segal. According to Ben-Dov, We [Bible scholars] have been wrestling with different theories for so many years, but biology is providing us with a new way to make our arguments.

Prof. Mizrahi sums up the field of scrolls research in the following way: We are adrift on an ocean of uncertainty, and scientific research creates a small island of probability in it. The more we increase knowledge, the more we discover more cogently how much we have left to discover.

Read more:
DNA unlocks the secrets of the Dead Sea Scrolls - Haaretz

Posted in Molecular Genetics | Comments Off on DNA unlocks the secrets of the Dead Sea Scrolls – Haaretz

Connecticut governor seeks 3rd party review of nursing homes – Thehour.com

Posted: June 13, 2020 at 4:47 pm

Susan Haigh, Associated Press

HARTFORD, Conn. (AP) Gov. Ned Lamont on Monday ordered an independent, third-party review of how Connecticut's nursing homes and assisted living centers prepared for and responded to the coronavirus pandemic, noting the findings could be helpful if the state faces a second wave this fall.

The Democrat said proposals will soon be solicited from third-party experts. In the meantime, he expects to meet with state lawmakers to determine the full scope of the review, which will include input from the operators of the long-term care facilities, unions representing the workers, patients, health experts and others.

Obviously that was the tragic center for our state and the other 49 states, in terms of fatalities," said Lamont, referring to the nursing homes. If there's a chance that there could be a second surge later on this summer, more likely in the fall, we want to be ready.

Lamont said a strong outside group will be able to focus on things like infection protocols, adequate supplies of personal protective equipment and what nursing homes might look like in the long-term.

To date, there have been more than 2,500 resident deaths from COVID-19 in nursing homes across Connecticut, a number that represents more than 60% of the state's total deaths, which grew to 4,084 on Monday.

Connecticut took various steps to try and stem the spread of the cononavirus in nursing homes, including halting visitations, eventually testing all residents and creating so-called COVID-recovery facilities where COVID-positive patients discharged from the hospital and moved from other homes could recuperate.

Representatives of Connecticut's two nursing home associations said they support Lamont's call for an independent investigation, but recommended it take into account how guidance changed from the U.S. Centers for Disease Control, the inadequate supply of PPE, delays in testing, and the prevalence of COVID-19 in the communities where the nursing homes and assisted living facilities are located.

On Monday, a national group representing assisted living centers across the U.S. called for $5 billion in emergency federal assistance. Josh Geballe, Lamont's COO, said state officials are monitoring the needs of assisted living centers in Connecticut, but noted nursing homes have been more financially precarious, requiring state assistance.

For most people, the virus causes mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness or lead to death.

In other coronavirus news in Connecticut:

____

MORE BUSINESSES REOPENING

Lamont said about 95% of the state's economy will be reopened as of June 17, so long as Connecticut's infection numbers remain low. That's when lodging, outdoor amusement parks, libraries, tattoo parlors, nail salons, gyms, pools, bowling alleys, and movie theaters will be allowed to open at limited capacities. Certain smaller outdoor events will also be allowed.

A third reopening is planned in July. Lamont said that's when bars may reopen, as well as indoor events.

____

INMATE SETTLEMENT

A settlement has been reached in a federal lawsuit that sought to better protect Connecticut prison inmates from the coronavirus. Announced over the weekend, it requires the Department of Correction to prioritize elderly and medically vulnerable prisoners who qualify for early release programs.

It also requires the department to provide prisoners better access to antiseptic cleaning supplies and allow those isolated after testing positive to have regular access to showers.

The American Civil Liberties Union of Connecticut had been seeking the widespread release of inmates, many of whom are housed in dormitory settings where social distancing is difficult. But the state had argued that a widespread release of inmates would jeopardize public safety.

The draft agreement notes the Department of Correction has begun the voluntary testing of all prisoners. It has also required the wearing of masks by staff and inmates outside their cells and has increased cleaning to limit spread of the disease.

The settlement must still be approved by a U.S. District Court judge.

___

STATE CAMPGROUNDS REOPENING

The Department of Energy and Environmental Protection plans to reopen campgrounds for summer camping beginning July 8. Campers with recreational vehicles or RVs will be able to keep their reservations starting July 1. Anyone with reservations before those dates will be provided refunds.

New reservations for the season can be made online beginning July 20.

DEEP is hiring and training staff to clean bathrooms and other facilities to maintain standards required by health officials during the coronavirus pandemic. The agency has also obtained protective gear and made safety changes to camp office buildings.

___

Associated Press Writer Pat Eaton-Robb contributed to this report.

Go here to see the original:
Connecticut governor seeks 3rd party review of nursing homes - Thehour.com

Posted in Connecticut Stem Cells | Comments Off on Connecticut governor seeks 3rd party review of nursing homes – Thehour.com

19 fun things to do in Hampshire with the family – Portsmouth News

Posted: June 13, 2020 at 4:45 pm

Fortunately there are dozens of fun things to do in Hampshire which are within an hours drive of Portsmouth.

Although we are still in lockdown because of the coronavirus pandemic, some attractions which had been closed are working on plans to reopen.

We have put together a list of activities, museums and heritage sites in our area you can enjoy with the family once lockdown is over.

Many of these places will be closed until government restrictions are lifted please check with the individual places website to see if they are open.

These include free things to do, as well as ones you can do if it is raining outside.

It displays ongoing constructions of Iron Age buildings based on real sites, crops from prehistory and rare breeds of animals.

There is loads of space for the kids to run around and the farms special events are worth checking out.

Little Woodham, near Gosport

Step back in time to the 17th century. Immerse yourself in the everyday life of people who lived in a small village in the 1600s.

Walk through real homes, watch weavers spinning wool or find the potter at his wheel.

There are hundreds of animals to admire at Marwell, including giraffes, tigers, meerkats, and penguins.

There are also three adventure playgrounds and a train, in case the animals arent enough to keep the little ones occupied.

A place to learn about the history of the industry. The building was saved because of its unique history when it closed in 1974 the men working there still worked in the same way as their Victorian and Edwardian forefathers.

Head over to Hinton Ampner, a country manor with a tranquil garden and breathtaking views across the South Downs. You can explore the garden, wander the estate, and discover the house, which was rebuilt following a fire in 1960.

The house is currently closed but the gardens and parkland are open.

Winchester Science Centre

Use a fully-functioning pinball machine to learn how we harness the potential of stem cells to repair our bodies, visit the Ancient Wisdom zone, or go on a journey of discovery through an enormous colon.

Yes, you read that right.

Hensting Alpacas, Eastleigh

If everyone needs a little fresh air, heres a fun way to trick the wee ones into walking. Hensting Alpacas like to take their animals out for a roam when the weather is good so the general public can come and meet them.

Uppark House and Gardens, Petersfield

Home to peaceful gardens, woodland for exploring and one of the best examples of a 17th century dolls house, Uppark illustrates the difference between comfortable life upstairs and the difficult life of servants downstairs.

The house is not currently open but the garden is open to visitors.

Portchester Castle was originally built late in the 3rd century and is the best-preserved of the Roman 'Saxon Shore' forts. You can visit the exhibition on the history of the castle and Portchester, and you can enjoy a family picnic surrounded by history.

This trail uses the Hayling Billy coastal path which runs along the west coast of Hayling Island. The five-mile round path is regularly used by walkers, cyclists and horse riders. The route starts at the car park at North Halt on Havant Road and is clearly signposted.

Alpine Snowsports, Southampton

The centre is a great place for new and experienced snowsports fans to have a go on the slopes. There are qualified instructors to take you through the basics of skiing and snowboarding, and they offer lessons for adults and juniors as well as childrens parties.

Fort Nelson is one of five defensive forts built on Portsdown Hill in the 1860s overlooking Portsmouth. Visit the museum to find out more about the collection of artillery and how it changed the nature of battles over hundreds of years. Admission is free.

This small, volunteer-led attraction is the UKs only museum dedicated to diving. There is a wide range of diving equipment including diving bells, chambers and atmospheric diving suits, as well as the prototype helmet used in the worlds first commercial dive.

Solent Sky Museum, Southampton

There are more than 20 aircraft to explore at the Solent Sky Museum, from the golden age of aviation. Among others you can learn the fascinating history of the Supermarine Spitfire F24, which has Southampton as its birthplace.

Spend the day with goats, pigs, rabbits and more at Manor Farm. On a rainy day you can also enjoy walking round the traditional barns and workshops, farmhouse and cottage.

Watercress Line, New Alresford

Take a ride on the popular heritage railway which runs between Alresford and Alton. In February and March 2020 there is a chance to see the world-famous Flying Scotsman locomotive on its tracks.

Titchfield Abbey was first built in the 13th century and was originally the home of a community of Premonstratensian canons. Later the buildings were transformed into a great Tudor house, featuring a grand turreted gatehouse.

See the article here:
19 fun things to do in Hampshire with the family - Portsmouth News

Posted in New Hampshire Stem Cells | Comments Off on 19 fun things to do in Hampshire with the family – Portsmouth News

Regenerative Therapy Options for Horses With Osteoarthritis – TheHorse.com

Posted: June 12, 2020 at 4:47 pm

Biologic, or regenerative, therapies have altered the way many equine veterinarians treat problematic joints. Some of the most mainstream and popular modalities they currently use to manage osteoarthritis (OA) in horses are autologous conditioned serum, autologous protein solution, platelet-rich plasma, and mesenchymal stem cells.

Most biologic therapies involve collecting and concentrating the horses natural anti-inflammatory and regenerative proteins or cells so they can be injected into an area of pathology (disease or damage) in the same horse.

Autologous conditioned serum is a cell-free extract of whole blood that has been processed to contain high concentrations of interleukin-1 receptor antagonist protein (IRAP), a naturally occurring anti-inflammatory protein within the body. It is marketed under the trade names IRAP and IRAP II.

When preparing ACS, veterinarians collect venous blood in a proprietary syringe system that encourages porous glass beads to bind with white blood cells. During an incubation process the bound white cells release high concentrations of IRAP. The veterinarian then draws the serum off into small portions and freezes it for future injection into arthritic joints. In clinical studies of ACS, researchers have reported improved synovial membrane (joint surface lining) health, stimulation of natural IRAP production, and improved lameness.

Platelet rich plasma is blood plasma thats been centrifuged or filtrated to have a higher concentration of platelets than whole blood. Many horse owners are familiar with PRP and its use in tendon and ligament injuries; however, veterinarians are using it more regularly for treating joint disease.

One of platelets roles in the body is to modulate tissue healing. They do so by releasing growth factors and signaling molecules that initiate repair and promote anabolic (supporting tissue growth) effects. Veterinarians have capitalized on this ability by injecting high concentrations of platelets directly into damaged or inflamed regions. Because many PRP systems allow for stallside preparation, it is a convenient option for immediate treatment without the hassle of incubation or culturing in the lab, as is the case with ACS and stem cell preparation, respectively.

Historically, equine veterinarians have primarily used PRP to help treat soft tissue injuries. More recent work has led to intra-articular (in the joint) use with promising results. Although researchers have demonstrated how platelet-derived products work in vitro (in the lab) and veterinarians have seen promising anecdotal results in vivo (in the live horse), theyve yet to produce evidence-based confirmation of its clinical efficacy.

Mark Revenaugh, DVM, owner of Northwest Equine Performance, in Mulino, Oregon, says the main factors standing between researchers ability to gather objective data and establish a consensus on PRPs efficacy are the high variability among preparation systems, individual patient reactivity to the product, and an unknown ideal concentration of platelets for particular injuries.

Most practitioners cant always check how many platelets are being used, he says. Depending on the system, one veterinarian may be using 100,000 platelets/milliliter and another veterinarian may be using 1 billion platelets/milliliter. These are not the same treatments, even though both are called PRP. I would love to see an industry standard develop.

Overall, PRPs positive anecdotal results and relatively easy preparation make it a useful option for treating osteoarthritis (OA) in horses.

Autologous protein solution (marketed under the trade name Pro-Stride) is essentially a hybrid of ACS and PRP. Its two-step stallside preparation process involves separating whole blood and sequestering white blood cells and platelets in a small fraction of plasma. The veterinarian then concentrates the separate blood components by filtration, leaving a solution of white blood cells, platelets, and serum proteins that provides the anti-inflammatory mediators of IRAP and the platelet-derived growth factors of PRP.

In a 2014 study out of The Ohio State University, researchers revealed that an intra-articular APS injection can significantly improve lameness, weight-bearing symmetry, and range of joint motion in horses that dont have severe lameness or significant compromise to the joint structure.

Mesenchymal stems cells are adult stem cells that can direct regeneration and repair of damaged tissue. Veterinarians have used this type of stem cell as a treatment strategy for equine soft tissue injury for some time; its only recently that veterinarians have begun using them to treat OA, and its not fully clear how they work in this capacity. Researchers working on early stem cell studies hoped to establish evidence that stem cells injected into regions of injury would develop into the respective tissue. While this hypothesis proved to be incorrect, continued research has revealed that these cells might instead have anti-inflammatory effects and the ability to recruit other stem cells to the area that could, in fact, heal damaged tissue.

The two most common forms of mesenchymal stem cells are adipose (fat)-derived and bone-marrow-derived. Some study results have shown that bone marrow sources yield smaller concentrations thanbut are superior toadipose sources in their ability to differentiate into musculoskeletal tissue. Some encouraging data supporting the use of mesenchymal stem cells for treating OA exists, but researchers have only published a small number of studies with promising results. Equine veterinarians have used MSCs to treat intra-articular soft tissue injury (meniscal and cruciate damagecartilaginous tissues and ligaments that support the stifle), with successful anecdotal results. Theyve reported more variable outcomes when using it for primary intra-articular injuries.

Carter Judy, DVM, Dipl. ACVS, staff surgeon at Alamo Pintado Equine Medical Center, in Los Olivos, California, says he currently prefers to use PRP and APS for OA treatment over MSCs. However, he admits there is much to be discovered. What will be interesting to see is how manipulating the cells and providing them with different signals and markers can make their efficacy much more potent and focused, he says.

When weighing treatment options for horses with OA, veterinarians should base their decision to use a certain biologic modality on its cost, availability, and how a horse has responded previously.

Our knowledge base of how the biologics work is improving, but we are in the infancy of understanding, Judy says. Much of the use is based on the clinical response as much as is it on the scientific data.

Here is the original post:
Regenerative Therapy Options for Horses With Osteoarthritis - TheHorse.com

Posted in Ohio Stem Cells | Comments Off on Regenerative Therapy Options for Horses With Osteoarthritis – TheHorse.com

Why Do Some People Get Sick All the Time, While Others Stay in Freakishly Good Health? – Discover Magazine

Posted: June 12, 2020 at 4:47 pm

This originally appeared in the July/August issue ofDiscovermagazine as "Titans of Immunity." Support our science journalism by becoming asubscriber.

For years, Melanie Mussons friends have marveled at her superpower: staying healthy no matter what germs are making the rounds. Colds and flu felled plenty of Mussons dormmates in college, but the viruses always seemed to pass her by. I never got sick once, she says. I got about five hours of sleep a night, I finished school in three years, and I worked 30 hours a week throughout. My best friends labeled me the machine.

Mussons ironclad immune system also set her apart at her first job. While she was working at an assisted living facility, her co-workers succumbed to a stomach virus that was running rampant. Undaunted, Musson offered to cover their shifts. There I was, the brand-new employee, getting as much overtime as I wanted. I wasnt worried that Id catch [the virus], because it just doesnt happen.

While the rest of us battle seasonal flu, chronic allergies and back-to-back wintertime colds, Musson and other immune masters glide through with scarcely a sniffle something University of Pittsburgh immunologist John Mellors sees all the time. People get exposed to the same virus, the same dose, even the same source. One gets very sick, and the other doesnt.

Its only natural to wonder: Why do some people always seem to fall on the right side of this equation? And could our own immune systems approach the same level with the right tuneup?

Doctors have noted natural variations in the immune response among people since Hippocrates time, but the reasons remained elusive for centuries. New research, however, is starting to illustrate just how your genes, habits and past disease exposures affect the character and strength of your immune response. These discoveries are helping to define the parameters of a race in which people like Musson have a head start and others have much more ground to cover.

The moment a virus, bacterium or other invader breaches your cells walls, your body rolls out a tightly choreographed defense strategy. The main architects of this process are a set of human leukocyte antigen (HLA) genes, which code for molecules that fine-tune the bodys immune response. So when a bacterium gets into one of your cells, your HLA genes churn out proteins that flag the cell as infected so that specialized immune cells will swarm in to destroy it. Other HLA genes activate cells that rein in the immune response, so it doesnt destroy more than necessary.

Like fingerprints, everyones HLA gene assortment is unique. Your HLA genes give you a broad repertoire of immune defense tactics, but that repertoire may be great for some microorganisms and lousy for others, Mellors says. Its not like theres one HLA type thats highly immune to everything. This genetic variation helps explain why you might catch every cold virus going around but havent gotten a stomach bug in decades. A Massachusetts General Hospital study found that some so-called HIV controllers immune stalwarts who dont develop AIDS from the virus HIV have HLA gene variants that prompt specialized cells to swarm in and attack proteins key to the virus function.

But your HLA genes arent the only ones that shape your immune resistance. The Human Genome Project has identified tens of thousands of gene variants that are more common in people who develop specific diseases and less common in people without these conditions.

Flagging these kinds of gene-disease links is a relatively simple matter, says immunologist Pandurangan Vijayanand of the La Jolla Institute for Immunology. After researchers identify a gene sequence thats linked to disease, however, they need to figure out what it is actually doing, says Vijayanand. How is this change in the sequence impacting the cell or causing the susceptibility [to disease]?

To answer this question, Vijayanand and his team are creating what they call an atlas, to catalog which proteins each gene produces and how these proteins change the function of different cell types. For example, he has identified a gene variant that makes people more prone to asthma a condition in which the body attacks its own healthy airway cells by driving high production of proteins that rev up the immune response. Other gene variants appear to help people fight lung tumors by prompting their tissues to produce more T lymphocytes, specialized immune shock troops that kill cancer cells.

While a dizzying number of genetic differences remain to be cataloged, immunologists agree that, in general, these differences help explain why resistance to some pathogens can seem to run in families. People like Melanie Musson probably get a genetic leg up to some degree Musson says her mother, father and siblings rarely get sick. Conversely (and unfairly), you might instead inherit a tendency to develop diabetes, recurrent strep infections or autoimmune diseases.

However anemic or hardy your innate immune arsenal, it supplies only the broad contours of your bodys resistance to threats. Environmental influences fill in the details, from where you live to your sleeping patterns to your history of previous infections.

In a 2015 Cell study, researchers studied more than 100 pairs of identical twins and how their immune systems responded to the flu shot. About three-quarters of the differences they saw were driven by environmental factors rather than genetic ones. The differences in twins immune systems also grew more pronounced the older they got, suggesting that outside influences continue to shape our immune potential over time.

Some of these influences show up in early childhood and may be hard to offset later on. Researchers have long known that children who live on farms are less likely to develop autoimmune diseases like asthma and allergies. An Ohio State University study from July 2019 hints at one reason why: Farm kids have a more diverse array of gut microbes than city kids, and the presence of some of these gut microbes predicts lower frequencies of immune cells that create allergic inflammation. Broad microbial exposure, in short, appears to train the immune system not to overreact to substances like animal dander.

But regardless of where you grew up, if youre unlucky enough to catch certain disease-causing bugs, they can throw your immunity off balance for years. Cytomegalovirus, a relative of the virus that causes chicken pox, stages its attack by reprogramming the human immune system. Some of the virus proteins latch onto certain immune cells, interfering with their ability to fight invaders. Other proteins, according to research from the University Medical Center Utrecht, interfere with the expression of key human HLA genes. And since cytomegalovirus infections are chronic, the resulting immune deficits can go on indefinitely.

Naturally, you cant control where youre raised or what random pathogens you acquire. But you can control your daily routine, what you put into your body and how you shield yourself against germs. In recent years, scientists have begun a full-fledged push to find out which lifestyle habits actually foster a robust immune system and which may be more hype than substance.

While the overall picture of how diet shapes immunity is still blurred, new studies do hint at the immune-strengthening effects of certain types of foods. Garlic, for instance, contains a sulfur compound called allicin, which spurs production of disease-fighting immune cells like macrophages and lymphocytes in response to threats.

(Credit: Lucky_Find/Shutterstock)

Researchers also report that specific bacteria-containing foods such as sauerkraut, kimchi and kefir produce an immunologically active substance called D-phenyllactic acid. This acid appears to signal immune cells, called monocytes, to report for duty by binding to a receptor protein on the cells surfaces. When people eat sauerkraut, very soon afterward, we see in the blood that theres an increase in the level of this substance, says Leipzig University biologist Claudia Stubert. In future studies, she hopes to clarify exactly how the acid affects monocytes activity in the body.

In addition to tweaking their diets, many titans of immunity embark on intense exercise regimens to keep their health robust. I swim and snorkel year-round in the ocean, up to a mile at a clip, from New England to Miami and a few secluded points in between, says Baron Christopher Hanson, a business consultant who claims he almost never gets sick. But so far, scientific proof that exercise improves immunity is limited. While a new study in rats shows that regular exercise changes the prevalence of different types of immune cells, it isnt clear whether these changes make you less likely to get sick.

Getting your daily quota of shut-eye, however, does seem to boost your immunity. Repeated studies show that sleep revs up your immune response, and a recent one from Germanys University of Tbingen reports that it does so in part by preparing disease-fighting T cells to do their jobs more effectively. Thats because your body churns out more integrins proteins that help T cells attach to germ-infected cells and destroy them while youre asleep.

But while getting more sleep could help snap your streak of winter colds, squirting your palms with hand sanitizer may not. In numerous studies, plain old soap and water was shown to kill germs better than sanitizer does. Hand sanitizer is great for alcohol-susceptible bugs, but not all bugs are susceptible, Mellors points out. Whats more, using sanitizer wont have any lasting effects on your immunity. The moment you touch another germy surface, your thin layer of protection will vanish.

Getting plenty of sleep is one way to boost your immune health: The body preps disease-fighting cells while youre asleep. (Credit: Realstock/Shutterstock)

Champions of immunity tend to credit their daily habits with keeping them healthy. But many have also lucked into an ideal balance between effector T cells, the frontline immune soldiers that fend off pathogens, and regulatory T cells, which keep the bodys immune arsenal in check so it wont over-respond to threats. An overactive immune system can be just as troublesome as an underactive one autoimmune conditions like rheumatoid arthritis, multiple sclerosis and allergies all stem from an immune response thats too forceful and sustained.

Last year, scientists at Kyoto University in Japan and elsewhere described one potential way to redress this kind of imbalance: turning effector T cells into regulatory T cells in the lab. Autoimmune episodes are triggered by antigens binding to [a] receptor on effector T cells, says molecular biologist Shuh Narumiya, one of the papers authors. When Narumiya and his colleagues used an inhibitor chemical to block an enzyme that controls cell development, cells that would normally develop into effector T cells turned into regulatory T cells instead a tweak that dialed down harmful autoimmune responses in mice.

While not everyone needs such immune fine-tuning, some people could potentially benefit from a treatment based on this technique, Narumiya says. Filling out the ranks of regulatory T cells could someday help keep a range of disabling autoimmune conditions under control.

Regardless of your T cell balance or your immune track record, theres a hefty dose of serendipity involved each time your immune system faces a threat. You might consider yourself forever prone to the flu or sniffles, but an X-factor a cross-country move, a dietary tweak, a new therapy can unexpectedly realign things and boost your immune potential.

By the same token, no matter how stalwart your HLA gene arsenal, how sound your sleep or how scrupulous your hygiene, you can end up knocked flat with a nasty bug when you least expect it. Immune health is like a gigantic roulette wheel. You throw the ball down and where it lands is a matter of chance, Mellors says. You have an encounter with a pathogen, and at the time you get exposed, your front line is not up to snuff. Even titans of immunity can have Achilles heels and even immune systems that seem licked at the beginning can pull off unlikely victories.

Its a recurring theme of the COVID-19 crisis: Those infected with the virus develop vastly different symptoms. Some barely feel anything a scratchy throat, if that while others spend weeks in the ICU with ravaged lungs, unable to breathe on their own. This wide variation in how people respond to SARS-CoV-2 stems, in part, from each persons unique genetic and lifestyle factors that affect their immune function.

(Credit: Andrii Vodolazhskyi/Shutterstock)

Scientists in Sydney and Hong Kong have found a particular gene variant tied to high rates of severe symptoms of SARS, a coronavirus related to the one that causes COVID-19. Because the novel coronavirus only recently appeared in humans, we dont know exactly which genetic quirks might make us more susceptible to it. Scientists are now investigating whether other specific genes might give some people higher or lower degrees of protection against the virus.

In some older people, or in those who have underlying immune deficits from chronic conditions, regulatory T cells which usually keep immune responses under control do not function normally. When these people get COVID-19, so-called cytokine storms may cause excessive inflammation in the lungs, leading to life-threatening symptoms. A study conducted by researchers in China found that COVID-19 patients with severe illness had lower levels of regulatory T cells in their bloodstream. Children may be less prone to disabling symptoms because their immune systems are better regulated and they have fewer underlying conditions.

SARS-CoV-2 uses a cell surface receptor called ACE2 to enter the cells that line your respiratory tract. New research shows that in smokers, these receptors are more prevalent in the lungs, creating more potential access routes for the virus. If you smoke, says Boston Childrens Hospital immunologist Hani Harb, the virus will be able to enter more cells in higher numbers.

Elizabeth Svoboda is a science writer in San Jose, California. Her most recent book is The Life Heroic: How To Unleash Your Most Amazing Self.

Read more from the original source:
Why Do Some People Get Sick All the Time, While Others Stay in Freakishly Good Health? - Discover Magazine

Posted in Ohio Stem Cells | Comments Off on Why Do Some People Get Sick All the Time, While Others Stay in Freakishly Good Health? – Discover Magazine

Study finds little evidence to back cord-blood therapy for autism – Spectrum

Posted: June 12, 2020 at 4:43 pm

Infusion in question: Cord-blood therapies have failed to ease autism traits in a series of ongoing clinical trials.

Burger / Science Photo Library

An infusion of umbilical cord blood does not improve social skills in autistic children, according to results from the largest clinical trial of the therapys effectiveness for autism to date1.

Independent experts say the findings are unfortunate but not unexpected. Doubts have surrounded the trial since its start at Duke University in Durham, North Carolina, in 2014.

Its not a surprise; it is nonetheless a disappointment, says Arnold Kriegstein, professor of neurology at the University of California, San Francisco, who was not involved in the study. Ive been skeptical of this kind of treatment from the beginning.

The new study took a rigorous approach: The Duke team randomly assigned 180 autistic children aged 2 to 7 to receive a single infusion of cord blood or a placebo. Neither the researchers nor caregivers knew which children had received cord blood when the team evaluated them six months later. But at that point, the participants traits remained largely unchanged. The results were published in May in the The Journal of Pediatrics.

The work is very good quality, and they are honest in their results, says Michael Chez, a pediatric neurologist at the Sutter Institute for Medical Research in Sacramento, California, who conducted a small trial in 2018 showing cord-blood therapy was safe in children with autism2.

Despite the new trials failure, the Duke researchers are moving ahead with a study using cells derived from umbilical cords, building on the observation that the treatment may have improved social behavior among the participants with the highest intellectual abilities.

I feel encouraged by the results, says co-lead investigator Joanne Kurtzberg, director of Dukes Marcus Center for Cellular Cures. It wasnt a home run, but there are reasons why we gained valuable information.

Umbilical cord blood contains a wide variety of cells, including immune cells known as monocytes and blood-producing stem cells involved in proven therapies for blood cancers.

The researchers theorize that molecules released by the monocytes quell brain inflammation. Studies show that inflammation in the womb can shape brain development and may boost the odds of autism. Some researchers have proposed that an overactive immune response might ease autism traits in some children.

Longtime skeptics of the Duke study, including Kriegstein, point out that a single infusion of these cells is unlikely to have a lasting impact or reverse damage already done.

In response to rising demand from parents for unproven stem-cell therapies, Kurtzberg, who is a cord-blood pioneer, launched the trial together with Geraldine Dawson, director of Duke Universitys Center for Autism and Brain Development, with funding from the Marcus Foundation.

The researchers tested two types of cord blood: 56 children received cord blood banked at their own birth, and 63 received cord blood from an unrelated donor. The analyses found no statistically significant differences between the groups six months later. The children who had injections were comparable to controls in terms of social skills, as reported by their parents, and overall autism traits, measured in a clinical evaluation.

The treatment may have had a small effect in some individuals, particularly those receiving donated cord blood, the researchers say. Children with the highest intelligence quotient (IQ) scores appeared to show some improvements in social skills following the infusions.

The results are, at best, only suggestive in a subgroup of patients, says Gahan Pandina, an autism researcher at Janssen Research and Development in New Jersey.

One shortcoming of the study is that it includes too few autistic children without intellectual disability, Dawson and Kurtzberg say. They used medical records and video to screen participants before they were enrolled and then invited them to travel to Duke for on-site evaluations. But this strategy meant they initially overlooked intellectual disability in some children, particularly in the younger ones, and so they ended up with fewer high-IQ participants than expected.

In the new trial they have launched, dubbed the Duke IMPACT trial, they are enrolling a slightly older cohort to improve their ability to track participants without intellectual disability, and they are conducting all evaluations on site prior to recruitment. They will also use mesenchymal stromal cells (MSC) grown from donated cord tissue rather than monocyte-containing cord blood. Like monocytes, MSCs release molecules that might decrease inflammation, the researchers say.

Follow this link:
Study finds little evidence to back cord-blood therapy for autism - Spectrum

Posted in North Carolina Stem Cells | Comments Off on Study finds little evidence to back cord-blood therapy for autism – Spectrum

GLOBAL BIOTECHNOLOGY ALGAE CULTIVATION PROCESS (MICRO ALGAE) MARKET REPORT 2020: SIZE 2019: BENEFITS, DEMAND GROWTH, KEY SEGMENTS, TOP BRANDS AND…

Posted: June 11, 2020 at 4:47 am

The Global Biotechnology Algae Cultivation Process (Micro Algae) Market report offers users the detailed study of the market and its main aspects. There are different marketing strategies that every marketer looks up to in order to ace the competition in the Global market. Some of the primary marketing strategies that is needed for every business to be successful are Passion, Focus, Watching the Data, Communicating the value To Your Customers, Your Understanding of Your Target Market. There is a target set in market that every marketing strategy has to reach. A significant development has been recorded by the market of Biotechnology Algae Cultivation Process (Micro Algae), in past few years. It is also for it to grow further. Various important factors such as market trends, revenue growth patterns market shares and demand and supply are included in almost all the market research report for every industry. A systematized methodology is used to make a Report on the Global Biotechnology Algae Cultivation Process (Micro Algae) market. For the analysis of market on the terms of research strategies, these techniques are helpful. All the information about the Products, manufacturers, vendors, customers and much more is covered in research reports.

The Global Biotechnology Algae Cultivation Process (Micro Algae) market is a highly competitive market with a huge number of vendors. Out of this number, there are some players that has been in this game for quite a time now and made it big for themselves. Whereas, there are many new startups as well who are coming up well. The market analysis is done by the methods such as SWOT analysis and PESTEL analysis. It is very important for any business to keep coming up with new ideas in order to stand out in the industry. To identify what makes the business stand out and to take the chance to gain advantage from these findings, SWOT analysis is used by marketers. Whereas PESTEL analysis is the study concerning Economic, Technological, legal, political, social, environmental matters. External factors affecting the market are determined by PESTEL analysis. PESTEL analysis making strategies and planning for all the types of business that may be opening a new company in a new location or an expansion of a product line. For the analysis of market on the terms of research strategies, these techniques are helpful.

Access the PDF sample of the report @https://www.orbisresearch.com/contacts/request-sample/2382077

Biotechnology algae cultivation process like algaculture is a form of aquaculture involving the farming of species of algae.

The majority of algae that are intentionally cultivated fall into the category of microalgae (also referred to as phytoplankton, microphytes, or planktonic algae).

According to this study, over the next five years the Biotechnology Algae Cultivation Process (Micro Algae) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Biotechnology Algae Cultivation Process (Micro Algae) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Biotechnology Algae Cultivation Process (Micro Algae) market by product type, application, key companies and key regions.

This study considers the Biotechnology Algae Cultivation Process (Micro Algae) value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 10.7.

Euglenophyta (Euglenoids)

Chrysophyta (Golden-Brown Algae and Diatoms)

Chlorophyta (Green Algae)

Rhodophyta (Red Algae)

Paeophyta (Brown Algae)

Xanthophyta (Yellow-Green Algae)

Others

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 10.8.

Food

Fertilizer and Agar

Pollution Control

Energy Production

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Cellana

Ecoduna

Algenol Biofuels

Solix Biofuels

Sapphire Energy

Solazyme

Seambiotic

LGem

Cyanotech

DENSO

Mialgae

Neoalgae

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Biotechnology Algae Cultivation Process (Micro Algae) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Biotechnology Algae Cultivation Process (Micro Algae) market by identifying its various subsegments.

Focuses on the key global Biotechnology Algae Cultivation Process (Micro Algae) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Biotechnology Algae Cultivation Process (Micro Algae) with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Biotechnology Algae Cultivation Process (Micro Algae) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Browse the full report @https://www.orbisresearch.com/reports/index/global-biotechnology-algae-cultivation-process-micro-algae-market-growth-status-and-outlook-2018-2023

Table of Contents

2018-2023 Global Biotechnology Algae Cultivation Process (Micro Algae) Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biotechnology Algae Cultivation Process (Micro Algae) Market Size 2013-2023

2.1.2 Biotechnology Algae Cultivation Process (Micro Algae) Market Size CAGR by Region

2.2 Biotechnology Algae Cultivation Process (Micro Algae) Segment by Type

2.2.1 Euglenophyta (Euglenoids)

2.2.2 Chrysophyta (Golden-Brown Algae and Diatoms)

2.2.3 Pyrrophyta (Fire Algae)

2.2.4 Chlorophyta (Green Algae)

2.2.5 Rhodophyta (Red Algae)

2.2.6 Paeophyta (Brown Algae)

2.2.7 Xanthophyta (Yellow-Green Algae)

2.2.8 Others

2.3 Biotechnology Algae Cultivation Process (Micro Algae) Market Size by Type

2.3.1 Global Biotechnology Algae Cultivation Process (Micro Algae) Market Size Market Share by Type (2013-2018)

2.3.2 Global Biotechnology Algae Cultivation Process (Micro Algae) Market Size Growth Rate by Type (2013-2018)

2.4 Biotechnology Algae Cultivation Process (Micro Algae) Segment by Application

2.4.1 Food

2.4.2 Fertilizer and Agar

2.4.3 Pollution Control

Read the original here:
GLOBAL BIOTECHNOLOGY ALGAE CULTIVATION PROCESS (MICRO ALGAE) MARKET REPORT 2020: SIZE 2019: BENEFITS, DEMAND GROWTH, KEY SEGMENTS, TOP BRANDS AND...

Posted in Biotechnology | Comments Off on GLOBAL BIOTECHNOLOGY ALGAE CULTIVATION PROCESS (MICRO ALGAE) MARKET REPORT 2020: SIZE 2019: BENEFITS, DEMAND GROWTH, KEY SEGMENTS, TOP BRANDS AND…

4 Biotechnology Stocks I’m Buying on Weakness – RealMoney – TheStreet

Posted: June 11, 2020 at 4:47 am

The S&P 500 is hitting its low point of the day as the FAANG names have reversed lower and breadth runs negative. There isn't any major rush for the exits but the momentum is more concentrated on some of the "economic reopening" plays such as the airlines and Boeing (BA) . Small-cap speculation has slowed and the Russell 2000 ETF (IWM) is struggling.

It isn't just the bears that would welcome a pullback in this market, many bulls would like some better entry points and weakness to buy. Chasing stocks higher day after day grows tiresome when you still have idle cash to put to work. Trying to stay in tune with a market that seems to be acting without regard to the news flow so often is quite exhausting.

While I'm not anticipating any major market pullback, I am looking for some signs that we may have some brief corrective action. At the top of my list is an intraday reversal and a poor close. We have the intraday reversal Thursday but it is fairly mild and we have to wait to see if there is any acceleration of selling into the close.

Even with that sort of action, it is going to be tough for the bears to gain downside traction, especially since bad news doesn't seem to produce any negative response. We have a long list of negative developments to explain some downside action but we just haven't had any come to fruition.

One the strategies I'm developing right now is to slowly start to build some longer term positions in a few biotechnology names as the pullback developes. This remains one of my favorite groups as it is relatively insulated from the ongoing coronavirus sector.

Four biotechnology names I'm looking to buy on weakness are Personalis (PSNL) , Ocular Therapeutix (OCUL) , Aurinia Pharmaceuticals (AUPH) (one of my stock picks for 2020) and Baduax Bio (BXRX) .

I don't see any rush to load up on these names but I'll be watching to make some smaller buys as the market action develops.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Read the original:
4 Biotechnology Stocks I'm Buying on Weakness - RealMoney - TheStreet

Posted in Biotechnology | Comments Off on 4 Biotechnology Stocks I’m Buying on Weakness – RealMoney – TheStreet

Should Level Biotechnology (GTSM:3118) Be Disappointed With Their 16% Profit? – Simply Wall St

Posted: June 11, 2020 at 4:47 am

Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right individual stocks, you could make more than that. For example, the Level Biotechnology Inc. (GTSM:3118) share price is up 16% in the last year, clearly besting the market return of around 9.9% (not including dividends). Thats a solid performance by our standards! Unfortunately the longer term returns are not so good, with the stock falling 2.1% in the last three years.

Check out our latest analysis for Level Biotechnology

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term its a weighing machine. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During the last year Level Biotechnology grew its earnings per share (EPS) by 16%. The similarity between the EPS growth and the 16% share price gain really stands out. That suggests that the market sentiment around the company hasnt changed much over that time. It makes intuitive sense that the share price and EPS would grow at similar rates.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Level Biotechnologys TSR for the last year was 20%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return.

Its good to see that Level Biotechnology has rewarded shareholders with a total shareholder return of 20% in the last twelve months. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 5.3% per year), it would seem that the stocks performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, weve identified 4 warning signs for Level Biotechnology (1 cant be ignored) that you should be aware of.

We will like Level Biotechnology better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on TW exchanges.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.

Read this article:
Should Level Biotechnology (GTSM:3118) Be Disappointed With Their 16% Profit? - Simply Wall St

Posted in Biotechnology | Comments Off on Should Level Biotechnology (GTSM:3118) Be Disappointed With Their 16% Profit? – Simply Wall St

Nanoparticles in Biotechnology and Pharmaceuticals Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Trends, Opportunities…

Posted: June 11, 2020 at 4:47 am

A new market report by Verified Market Research on the Nanoparticles in Biotechnology and Pharmaceuticals Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Nanoparticles in Biotechnology and Pharmaceuticals sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.verifiedmarketresearch.com/download-sample/?rid=19246&utm_source=COD&utm_medium=007

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Nanoparticles in Biotechnology and Pharmaceuticals manufacturers/companies operating at both regional and global levels:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Nanoparticles in Biotechnology and Pharmaceuticals Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=19246&utm_source=COD&utm_medium=007

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Nanoparticles in Biotechnology and Pharmaceuticals. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Verified Market Research

Customized Research Report Using Corporate Email Id @ https://www.verifiedmarketresearch.com/product/Nanoparticles-in-Biotechnology-and-Pharmaceuticals-Market/?utm_source=COD&utm_medium=007

Customization of the Report:

Verified Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Nanoparticles in Biotechnology and Pharmaceuticals market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll Free: +1 (800)-7821768

Email: [emailprotected]

See the article here:
Nanoparticles in Biotechnology and Pharmaceuticals Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Trends, Opportunities...

Posted in Biotechnology | Comments Off on Nanoparticles in Biotechnology and Pharmaceuticals Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Trends, Opportunities…